Neogenomics Inc’s recent filing unveils that its General Counsel Olivo Alicia C unloaded Company’s shares for reported $79475.0 on Nov 15 ’24. In the deal valued at $15.36 per share,5,175 shares were sold. As a result of this transaction, Olivo Alicia C now holds 37,129 shares worth roughly $0.3 million.
Then, ALICIA OLIVO bought 5,175 shares, generating $81,713 in total proceeds.
Before that, Olivo Alicia C sold 1,040 shares. Neogenomics Inc shares valued at $16,695 were divested by the General Counsel at a price of $16.05 per share. As a result of the transaction, Olivo Alicia C now holds 43,813 shares, worth roughly $0.36 million.
The Benchmark Company downgraded its Neogenomics Inc [NEO] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. BTIG Research maintained its rating on December 29, 2023. It rated NEO as “a Buy”.
Price Performance Review of NEO
On Tuesday, Neogenomics Inc [NASDAQ:NEO] saw its stock fall -7.13% to $8.20. Over the last five days, the stock has lost -12.30%. Neogenomics Inc shares have fallen nearly -50.24% since the year began. Nevertheless, the stocks have fallen -45.04% over the past one year. While a 52-week high of $19.11 was reached on 01/08/25, a 52-week low of $8.15 was recorded on 04/07/25. SMA at 50 days reached $11.14, while 200 days put it at $14.39.
Levels Of Support And Resistance For NEO Stock
The 24-hour chart illustrates a support level at 7.83, which if violated will result in even more drops to 7.47. On the upside, there is a resistance level at 8.89. A further resistance level may holdings at 9.59. The Relative Strength Index (RSI) on the 14-day chart is 31.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.77, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.75%. Stochastics %K at 19.05% indicates the stock is a buying.
How much short interest is there in Neogenomics Inc?
A steep rise in short interest was recorded in Neogenomics Inc stocks on 2025-03-14, growing by 0.79 million shares to a total of 4.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.43 million shares. There was a rise of 18.7%, which implies that there is a positive sentiment for the stock.
